MDI News

(MDI) MONCTON, New Brunswick, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (“Major Drilling” or the “Company”) (TSX: MDI), the largest provider of specialized drilling services to the mining sector, is pleased to announce that all director nominees listed in the Management Information Circular dated July 17, 2025 (the “Circular”) were elected as directors of Major Drilling in the course of the hybrid annual general meeting of shareholders of the Corporation (the “Meeting”) held September 9, 2025. Shareholder participation was high, with the total percentage of shares voted reaching over 83% (representing 68,665,121 common shares of the Corporation).

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., will be available for direct purchase from MedImpact’s preferred partner, Birdi, Inc., by any licensed specialty pharmacy. “Today, a drug’s cost rises at each step in the supply chain,” said Arpit Patel,